Quest, Inovalon roll out personalized Dx reports to prepare for demise of fee-for-service payments

Quest Diagnostics ($DGX) and Bowie, MD-based healthcare analytics company Inovalon touted the nationwide rollout of their Big Data analytics platform in anticipation of the trend toward value-based payments and the gradual demise of the fee-for-service model. Last year, the U.S. Department of Health & Human Services set the unprecedented goal of aligning 90% of all Medicare fee-for-service payments to quality and value by 2018.

The company's Data Diagnostics report contains specific actions a physician can take to efficiently improve an individual's outcomes, as called for under emerging payment models. They can be ordered by clinicians at the point of care in a manner similar to lab tests, according to a release.

"Examples include identifying a patient who is overdue to receive guideline-recommended cancer screening, has a heightened risk of disease progression or is receiving redundant testing and other unnecessary services," the companies say in release, adding: "Comprehensive medical histories for first time patients and emergency the care, among other analyses, are also available on demand in real time."

The reports can be accessed via laptop, mobile device or electronic health records that are supported by Quest, and help overcome the poor integration of the various EHRs, according to the release.

Inovalon CEO Dr. Keith Dunleavy

"Today physicians, hospitals, health plans, and the myriad of integrated healthcare delivery systems are being held to the achievement of certain quality standards and value-based shared risk arrangements, yet they have very limited, if any, insight into timely patient-specific gaps in quality, risk and utilization at the point of care--where it is needed most," said Inovalon CEO Dr. Keith Dunleavy in a statement. "Data Diagnostics was designed to address that challenge. The sophisticated but simple to use platform not only has the ability to integrate and aggregate vast amounts of data, but also to analyze this data at tremendous speeds across hundreds of critical performance measures, enabling physicians to better assess gaps in care, help improve outcomes and achieve incentive quality metrics in real-time. This is a game changer for healthcare."

The companies said they will demonstrate Data Diagnostics at the upcoming Healthcare Information and Management Systems Society in Chicago.

- read the release

Suggested Articles

Battelle received an emergency go-ahead from the FDA over the weekend to deploy its decontamination system for N95 respirator masks.

The limited supply of ventilators is one of the chief concerns facing hospitals as they prepare for more COVID-19 cases.

In one of the longest studies to date in high-risk heart disease, researchers found no significant difference in death rates over more than 10 years.